Understanding Genetic Diversity and Natural Selection for Vaccine Development

Jim Crocker
16th July, 2024

Understanding Genetic Diversity and Natural Selection for Vaccine Development

Recombination analysis supports the high genetic diversity observed in the vir 12 and vir 21 genes of Plasmodium vivax by identifying multiple recombination events, which were absent in the more conserved vir 4 and vir 27 genes.

Image adapted from: Hawadak et al. / CC BY (Source)

Key Findings

  • The study analyzed the genetic diversity of malaria parasites in Southeast Asia and sub-Saharan Africa
  • High genetic diversity was found in key genes of Plasmodium falciparum and Plasmodium vivax, complicating vaccine development
  • The findings highlight the need for vaccines targeting a wide range of antigenic variants to be effective
Malaria remains a significant global health challenge, particularly in regions such as Southeast Asia, sub-Saharan Africa, and South America. One of the key factors complicating the control and eradication of malaria is the genetic diversity of the parasites responsible for the disease. Recent research from the ICMR-National Institute of Malaria Research has delved into this issue by analyzing the genetic diversity and evolutionary patterns of specific genes in Plasmodium falciparum and Plasmodium vivax, the parasites responsible for the majority of malaria cases[1]. The study focused on variable surface antigens (VSAs) encoded by var and vir genes in P. falciparum and P. vivax, respectively. These antigens play a crucial role in malaria pathogenesis and the parasite's ability to evade the host's immune system through a process known as antigenic variation. Understanding the genetic diversity of these antigens is essential for developing effective vaccines and improving malaria control strategies. Previous studies have highlighted the importance of these genes in the survival and virulence of malaria parasites. For instance, the genome sequencing of P. vivax revealed novel gene families and potential alternative invasion pathways, providing valuable insights into the parasite's biology[2]. Additionally, the assembly and annotation of new reference sequences for P. vivax have significantly improved our understanding of its genetic makeup, particularly the extensive repertoire of Plasmodium interspersed repeat (pir) genes[3]. These genes are believed to play a vital role in the parasite's survival and development. In the current study, researchers analyzed two fragments (DBL2X and DBL3X) of the VAR2CSA gene in P. falciparum and four vir genes (vir 4, vir 12, vir 21, and vir 27) in P. vivax from different endemic regions, including Southeast Asia and sub-Saharan Africa. The study found high levels of genetic diversity in both var and vir genes, with significant variability in the number of segregating sites (S) and haplotype diversity (Hd). Specifically, vir 12 and vir 21 were found to be more diverse compared to vir 4 and vir 27, while the DBL2X and DBL3X fragments showed even higher genetic diversity. These findings are consistent with earlier research on the role of variant surface antigens in immune evasion and chronic infection. For example, studies on P. falciparum have demonstrated the critical role of var genes in maintaining antigenic diversity and avoiding host immune responses[4]. Similarly, the high turnover and diversity of var gene repertoires in individuals of all ages in malaria-endemic areas have been shown to contribute to the persistence of blood-stage infections despite lifelong exposure[5]. The high variability observed in the current study suggests that both var and vir genes are under balancing selection, a form of natural selection that maintains genetic diversity within a population. This balancing selection likely helps the malaria parasites evade the host's immune system by constantly changing their surface antigens, making it difficult for the immune system to mount an effective response. The implications of these findings are significant for malaria control and vaccine development. The high genetic diversity of var and vir genes means that any potential vaccine would need to target a wide range of antigenic variants to be effective. The study underscores the need for functional experimental studies to identify the most relevant allelic forms of these genes for vaccine formulation and testing. In conclusion, the research from the ICMR-National Institute of Malaria Research provides valuable insights into the genetic diversity and evolutionary patterns of key genes in P. falciparum and P. vivax. By highlighting the high variability of var and vir genes, the study underscores the challenges in developing effective vaccines and controlling malaria. These findings build on previous research and emphasize the importance of continued efforts to understand and combat this complex and adaptive disease.

MedicineBiotechGenetics

References

Main Study

1) Genetic diversity and natural selection analysis of VAR2CSA and vir genes: implication for vaccine development

Published 15th July, 2024

https://doi.org/10.1186/s44342-024-00009-0

Related Studies

2) Comparative genomics of the neglected human malaria parasite Plasmodium vivax.

https://doi.org/10.1038/nature07327

3) A new Plasmodium vivax reference sequence with improved assembly of the subtelomeres reveals an abundance of pir genes.

https://doi.org/10.12688/wellcomeopenres.9876.1

4) Small variant surface antigens and Plasmodium evasion of immunity.

https://doi.org/10.2217/fmb.10.21

5) Age-specific patterns of DBLα var diversity can explain why residents of high malaria transmission areas remain susceptible to Plasmodium falciparum blood stage infection throughout life.

https://doi.org/10.1016/j.ijpara.2021.12.001


Related Articles

An unhandled error has occurred. Reload 🗙